BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 28457319)

  • 1. Validation of a breast cancer nomogram to predict lymphedema in a Chinese population.
    Li X; Huang H; Lin Q; Yu Q; Zhou Y; Long W; Wang N
    J Surg Res; 2017 Apr; 210():132-138. PubMed ID: 28457319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms for predicting the risk of arm lymphedema after axillary dissection in breast cancer.
    Bevilacqua JL; Kattan MW; Changhong Y; Koifman S; Mattos IE; Koifman RJ; Bergmann A
    Ann Surg Oncol; 2012 Aug; 19(8):2580-9. PubMed ID: 22395997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a prospective surveillance model to prevent breast cancer treatment-related lymphedema: a single-center experience.
    Yang EJ; Ahn S; Kim EK; Kang E; Park Y; Lim JY; Kim SW
    Breast Cancer Res Treat; 2016 Nov; 160(2):269-276. PubMed ID: 27665585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer-related lymphedema after axillary lymph node dissection: does early postoperative prediction model work?
    Soran A; Menekse E; Girgis M; DeGore L; Johnson R
    Support Care Cancer; 2016 Mar; 24(3):1413-9. PubMed ID: 26349574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axillary nodal metastases in Italian early breast cancer patients with positive sentinel lymph node: can axillary node dissection be avoided by using predictive nomograms?
    Biolchini F; Vicentini M; Di Felice E; Giovanardi F; Antonio L; Giorgi Rossi P; Annessi V
    Tumori; 2015; 101(3):298-305. PubMed ID: 25838248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients.
    Ikeda K; Ogawa Y; Kajino C; Deguchi S; Kurihara S; Tashima T; Goto W; Nishiguchi Y; Tokunaga S; Fukushima H; Inoue T
    Eur J Surg Oncol; 2014 Jul; 40(7):818-23. PubMed ID: 24768416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Validation of a Nomogram to Predict Lymphedema After Axillary Surgery and Radiation Therapy in Women With Breast Cancer From the NCIC CTG MA.20 Randomized Trial.
    Gross JP; Whelan TJ; Parulekar WR; Chen BE; Rademaker AW; Helenowski IB; Donnelly ED; Strauss JB
    Int J Radiat Oncol Biol Phys; 2019 Sep; 105(1):165-173. PubMed ID: 31085285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of completion axillary lymph node dissection in patients with breast cancer and isolated tumour cells or micrometastases in sentinel nodes.
    Houvenaeghel G; Boher JM; Reyal F; Cohen M; Garbay JR; Classe JM; Rouzier R; Giard S; Faure C; Charitansky H; Tunon de Lara C; Daraï E; Hudry D; Azuar P; Gimbergues P; Villet R; Sfumato P; Lambaudie E
    Eur J Cancer; 2016 Nov; 67():106-118. PubMed ID: 27640137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Residual lymph node disease after neoadjuvant chemotherapy predicts an increased risk of lymphedema in node-positive breast cancer patients.
    Specht MC; Miller CL; Skolny MN; Jammallo LS; O'Toole J; Horick N; Isakoff SJ; Smith BL; Taghian AG
    Ann Surg Oncol; 2013 Sep; 20(9):2835-41. PubMed ID: 23689935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and Validation of an Intraoperative Nomogram to Predict Breast Cancer-Related Lymphedema Based on the Arm Lymphatics Distribution.
    Yuan Q; Hou J; Zhou R; Liao Y; Zheng L; Jiao C; Zhou W; Wu G
    Ann Surg Oncol; 2021 Nov; 28(12):7319-7328. PubMed ID: 33891201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors Associated With Lymphedema in Women With Node-Positive Breast Cancer Treated With Neoadjuvant Chemotherapy and Axillary Dissection.
    Armer JM; Ballman KV; McCall L; Ostby PL; Zagar E; Kuerer HM; Hunt KK; Boughey JC
    JAMA Surg; 2019 Sep; 154(9):800-809. PubMed ID: 31314062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment factors affecting breast cancer-related lymphedema after systemic chemotherapy and radiotherapy in stage II/III breast cancer patients.
    Jung SY; Shin KH; Kim M; Chung SH; Lee S; Kang HS; Lee ES; Kwon Y; Lee KS; Park IH; Ro J
    Breast Cancer Res Treat; 2014 Nov; 148(1):91-8. PubMed ID: 25253173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model to estimate the risk of breast cancer-related lymphedema: combinations of treatment-related factors of the number of dissected axillary nodes, adjuvant chemotherapy, and radiation therapy.
    Kim M; Kim SW; Lee SU; Lee NK; Jung SY; Kim TH; Lee ES; Kang HS; Shin KH
    Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):498-503. PubMed ID: 23541809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Preoperative Magnetic Resonance Imaging Radiomics-Based Signature to Predict Axillary Lymph Node Metastasis and Disease-Free Survival in Patients With Early-Stage Breast Cancer.
    Yu Y; Tan Y; Xie C; Hu Q; Ouyang J; Chen Y; Gu Y; Li A; Lu N; He Z; Yang Y; Chen K; Ma J; Li C; Ma M; Li X; Zhang R; Zhong H; Ou Q; Zhang Y; He Y; Li G; Wu Z; Su F; Song E; Yao H
    JAMA Netw Open; 2020 Dec; 3(12):e2028086. PubMed ID: 33289845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative validation of online nomograms for predicting nonsentinel lymph node status in sentinel lymph node-positive breast cancer.
    Hessman CJ; Naik AM; Kearney NM; Jensen AJ; Diggs BS; Troxell ML; Vetto JT
    Arch Surg; 2011 Sep; 146(9):1035-40. PubMed ID: 21931000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a nomogram incorporating axillary lymph node ratio to predict survival in node-positive breast cancer patients after neoadjuvant chemotherapy.
    Lai J; Pan Z; Chen P; Ye G; Chen K; Su F
    Jpn J Clin Oncol; 2019 Jan; 49(1):22-28. PubMed ID: 30508184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary lymph node dissection in the case of sentinel lymph node micrometastatic invasion: evaluation of three predictive models.
    Orsoni M; Clerc J; Golfier F; Cortet M; Raudrant D; Krauth JS
    Eur J Obstet Gynecol Reprod Biol; 2011 Oct; 158(2):334-7. PubMed ID: 21669485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.